Other
Comorbidities
Comorbidities is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completed
EWSs and 28-Day Mortality in Geriatric ED Patients
NCT07577349
completed
Prehospital ETI in OHCA
NCT07524881
completed
Predicting 28-Day Survival in OHCA Patients
NCT07023159
completed
COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina)
NCT05087394
completed
Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors
NCT03967496
Clinical Trials (5)
Showing 5 of 5 trials
NCT07577349
EWSs and 28-Day Mortality in Geriatric ED Patients
NCT07524881
Prehospital ETI in OHCA
NCT07023159
Predicting 28-Day Survival in OHCA Patients
NCT05087394
COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina)
NCT03967496
Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5